RU2018147200A3 - - Google Patents

Download PDF

Info

Publication number
RU2018147200A3
RU2018147200A3 RU2018147200A RU2018147200A RU2018147200A3 RU 2018147200 A3 RU2018147200 A3 RU 2018147200A3 RU 2018147200 A RU2018147200 A RU 2018147200A RU 2018147200 A RU2018147200 A RU 2018147200A RU 2018147200 A3 RU2018147200 A3 RU 2018147200A3
Authority
RU
Russia
Application number
RU2018147200A
Other languages
Russian (ru)
Other versions
RU2725493C2 (en
RU2018147200A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to RU2018147200A priority Critical patent/RU2725493C2/en
Publication of RU2018147200A3 publication Critical patent/RU2018147200A3/ru
Publication of RU2018147200A publication Critical patent/RU2018147200A/en
Application granted granted Critical
Publication of RU2725493C2 publication Critical patent/RU2725493C2/en

Links

RU2018147200A 2018-12-28 2018-12-28 System for stable expression of tumor-associated antigens based on lentiviral vector RU2725493C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2018147200A RU2725493C2 (en) 2018-12-28 2018-12-28 System for stable expression of tumor-associated antigens based on lentiviral vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018147200A RU2725493C2 (en) 2018-12-28 2018-12-28 System for stable expression of tumor-associated antigens based on lentiviral vector

Publications (3)

Publication Number Publication Date
RU2018147200A3 true RU2018147200A3 (en) 2020-06-30
RU2018147200A RU2018147200A (en) 2020-06-30
RU2725493C2 RU2725493C2 (en) 2020-07-02

Family

ID=71509391

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018147200A RU2725493C2 (en) 2018-12-28 2018-12-28 System for stable expression of tumor-associated antigens based on lentiviral vector

Country Status (1)

Country Link
RU (1) RU2725493C2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3307497A (en) * 1996-06-26 1998-01-14 Antigen Express, Inc. Immunotherapy by modulation of antigen presentation
US20100278904A1 (en) * 2005-11-30 2010-11-04 Copenhagen University Nucleotide vaccine
WO2010057501A1 (en) * 2008-11-21 2010-05-27 Københavns Universitet (University Of Copenhagen) Priming of an immune response
RU2507265C2 (en) * 2012-05-12 2014-02-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт клинической иммунологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИКИ" СО РАМН) RECOMBINANT PLASMID DNA pCI-UB-POLYEPI CONTAINING EPITOPES OF TUMOUR-ASSOCIATED ANTIGENS FOR COLORECTAL CANCER AND METHOD OF ITS APPLICATION FOR STIMULATION OF SPECIFIC ANTITUMOUR IMMUNE RESPONSE AGAINST COLORECTAL CANCER CELLS

Also Published As

Publication number Publication date
RU2725493C2 (en) 2020-07-02
RU2018147200A (en) 2020-06-30

Similar Documents

Publication Publication Date Title
BR112021012225A2 (en)
BR122022006221A2 (en)
BR122022015534A2 (en)
BR112020025288A2 (en)
BR112021008873A2 (en)
BR122022002102A2 (en)
AT524834A2 (en)
AT524874A5 (en)
AU2018438767B1 (en)
AT521543A3 (en)
AT524961A5 (en)
BR122022005529A2 (en)
BR122022016585A2 (en)
BR112020012832A2 (en)
BR202018071071U8 (en)
BR102018070765A2 (en)
BR102018016915A2 (en)
BE2018C025I2 (en)
BR202018008879U2 (en)
BR202018007669U2 (en)
BR202018006247U2 (en)
BR202018004136U2 (en)
BR202018002487U2 (en)
BR202018002069U2 (en)
CN304434459S (en)

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20210628

Effective date: 20210628